Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease

被引:8
|
作者
Siddiqui, Mohammad S. [1 ]
Patel, Samarth [1 ,2 ]
Forsgren, Mikael [3 ]
Bui, Anh T. [4 ]
Shen, Steve [1 ]
Syed, Taseen [1 ]
Boyett, Sherry [1 ]
Chen, Shanshan [5 ]
Sanyal, Arun J. [1 ]
Wolver, Susan [6 ]
Kirkman, Danielle [7 ]
Celi, Francesco S. [5 ]
Bhati, Chandra S. [8 ]
机构
[1] Virginia Commonwealth Univ, Div Gastroenterol & Hepatol, Richmond, VA USA
[2] Hunter Holmes McGuire VA, Div Gastroenterol & Hepatol, Richmond, VA USA
[3] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[4] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA USA
[5] Virginia Commonwealth Univ, Div Endocrinol Diabet & Metab, Richmond, VA USA
[6] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA
[7] Virginia Commonwealth Univ, Dept Kinesiol & Hlth Sci, Richmond, VA USA
[8] Virginia Commonwealth Univ, Div Transplant Surg, Richmond, VA USA
关键词
carbohydrates; energy expenditure; fatty acids; liver transplantation; metabolic flexibility; non-alcoholic steatohepatitis; RESTING ENERGY-EXPENDITURE; METABOLIC INFLEXIBILITY; OBESITY; STEATOHEPATITIS; PREVALENCE;
D O I
10.1111/liv.15178
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Metabolic flexibility is the ability to match biofuel availability to utilization. Reduced metabolic flexibility, or lower fatty acid (FA) oxidation in the fasted state, is associated with obesity. The present study evaluated metabolic flexibility after liver transplantation (LT). Methods Patients receiving LT for non-alcoholic steatohepatitis (NASH) (n = 35) and non-NASH (n = 10) were enrolled. NASH was chosen as these patients are at the highest risk of metabolic complications. Metabolic flexibility was measured using whole-body calorimetry and expressed as respiratory quotient (RQ), which ranges from 0.7 (pure FA oxidation) to 1.0 is (carbohydrate oxidation). Results The two cohorts were similar except for a higher prevalence of obesity and diabetes in the NASH cohort. Post-prandially, RQ increased in both cohorts (i.e. greater carbohydrate utilization) but peak RQ and time at peak RQ was higher in the NASH cohort. Fasting RQ in NASH was significantly higher (0.845 vs. 0.772, p < .001), indicative of impaired FA utilization. In subgroup analysis of the NASH cohort, body mass index but not liver fat content (MRI-PDFF) was an independent predictor of fasting RQ. In NASH, fasting RQ inversely correlated with fat-free muscle volume and directly with visceral adipose tissue. Conclusion Reduced metabolic flexibility in patients transplanted for NASH cirrhosis may precede the development of non-alcoholic fatty liver disease after LT.
引用
收藏
页码:1401 / 1409
页数:9
相关论文
共 50 条
  • [1] Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of "Seed and Soil"
    Dumortier, Jerome
    Giostra, Emiliano
    Belbouab, Soraya
    Morard, Isabelle
    Guillaud, Olivier
    Spahr, Laurent
    Boillot, Olivier
    Rubbia-Brandt, Laura
    Scoazec, Jean-Yves
    Hadengue, Antoine
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (03): : 613 - 620
  • [2] Utility of metabolomic biomarkers to identify non-alcoholic fatty liver disease in liver transplant recipients
    Mowry, Christopher
    Levitsky, Josh
    Alonso, Cristina
    Iruarrizaga-Lejarreta, Marta
    Pablo, Ortiz
    Rinella, Mary
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S428 - S428
  • [3] Non-Alcoholic Fatty Liver Disease in Lung Transplant
    Male, E.
    Liaquat, H.
    Agrawal, N.
    Mamary, A. J.
    Carney, K.
    Bronzell-Wynder, T.
    Criner, G. J.
    Mulhall, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [4] Non-Alcoholic Fatty Liver Disease in Non-Liver Transplant Patients
    Claudio, R.
    Conceicao, C.
    Robichaux, K.
    Kumar, A.
    Buggs, J.
    Kemmer, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 753 - 753
  • [5] INCREASED RISK OF NEUROLOGIC COMPLICATIONS FOR ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS WITH ALCOHOLIC LIVER DISEASE COMPARED TO TRANSPLANT RECIPIENTS WITH NON-ALCOHOLIC LIVER DISEASE
    Stedge, Bonnie
    Noll, Alan G.
    Lee, Frances
    Flynn, Mary
    Vora, Ravi
    Subramanian, Ram
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1337 - S1337
  • [6] Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
    Gitto, Stefano
    Villa, Erica
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04) : 1 - 11
  • [7] Dietary intake and its relationship with non-alcoholic fatty liver disease (NAFLD)
    Mosallaei, Zahra
    Mazidi, Mohsen
    Safariyan, Mohammad
    Norouzy, Abdolreza
    Mohajeri, Seyed Amir Reza
    Esmaily, Habibollah
    Bahari, Ali
    Ghayour-Mobarhan, Majid
    Nematy, Mohsen
    [J]. MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM, 2015, 8 (02) : 139 - 148
  • [8] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [9] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [10] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377